PUBLISHER: Grand View Research | PRODUCT CODE: 1433599
PUBLISHER: Grand View Research | PRODUCT CODE: 1433599
U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application (Orthopedic, Cardiovascular, Neurology, Drug Delivery, Ophthalmic, Nephrology and Urology Devices) And Segment Forecasts, 2024 - 2030
U.S. Medical Device Manufacturers Market Growth & Trends:
The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030 and is projected to expand at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.
The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.
Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.
The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.
U.S. Medical Device Manufacturers Market Report Highlights:
- Drug delivery devices held a dominant market share of 28.2% in 2023. Factors responsible for the estimated share include patient convenience and compliance, rising prevalence of chronic diseases, technological advancements to improve disease management, and increasing geriatric population.
- In March 2023, a team of scientists at Northwestern University, U.S., developed a novel drug-delivery technology that is expected to have implications for the opioid epidemic and cancer treatment and to improve rehabilitation care.
- The growing strategic initiative by industry leaders is also driving market growth
- In 2023, Medtronic and DaVita Inc. announced the launch of a new company, Mozarc Medical. The company aims to create solutions for kidney health.
- Furthermore, in 2023, GE HealthCare signed a USD 44 million contract with the Biomedical Advanced Research and Development Authority. Within this contract, GE is expected to provide diagnostic and imaging solutions to treat traumatic injuries.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in U.S.
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing geriatric population
- 3.2.1.2. High adoption of minimally invasive procedures
- 3.2.1.3. Increase in the number of sports and road accidents
- 3.2.1.4. Increasing geographic reach of market players
- 3.2.2. Market restraint analysis
- 3.2.2.1. Increase in the number of product recalls
- 3.2.2.2. Social and ethical issues
- 3.2.2.3. Slow approval procedures
- 3.2.1. Market driver analysis
- 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis
- 4.1. Application Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Orthopedic Devices
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.2. Cardiovascular Devices
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.3. Neurology Devices
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.4. Drug Delivery Devices
- 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.5. Ophthalmic Devices
- 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.6. Nephrology and Urology Devices
- 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.7. Others
- 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
- 4.4.1. Orthopedic Devices
Chapter 5. Competitive Landscape
- 5.1. Recent Developments & Impact Analysis, By Key Market Participants
- 5.2. Company/Competition Categorization
- 5.3. Vendor Landscape
- 5.3.1. Key company market share analysis, 2023
- 5.3.2. Stryker
- 5.3.2.1. Company overview
- 5.3.2.2. Financial performance
- 5.3.2.3. Product benchmarking
- 5.3.2.4. Strategic initiatives
- 5.3.3. Cardinal Health
- 5.3.3.1. Company overview
- 5.3.3.2. Financial performance
- 5.3.3.3. Product benchmarking
- 5.3.3.4. Strategic initiatives
- 5.3.4. Eli Lily and Company
- 5.3.4.1. Company overview
- 5.3.4.2. Financial performance
- 5.3.4.3. Product benchmarking
- 5.3.4.4. Strategic initiatives
- 5.3.5. Intuitive Surgical
- 5.3.5.1. Company overview
- 5.3.5.2. Financial performance
- 5.3.5.3. Product benchmarking
- 5.3.5.4. Strategic initiatives
- 5.3.6. Edwards Lifesciences Corporation
- 5.3.6.1. Company overview
- 5.3.6.2. Financial performance
- 5.3.6.3. Product benchmarking
- 5.3.6.4. Strategic initiatives
- 5.3.7. BD
- 5.3.7.1. Company overview
- 5.3.7.2. Financial performance
- 5.3.7.3. Product benchmarking
- 5.3.7.4. Strategic initiatives
- 5.3.8. Danaher
- 5.3.8.1. Company overview
- 5.3.8.2. Financial performance
- 5.3.8.3. Product benchmarking
- 5.3.8.4. Strategic initiatives
- 5.3.9. 3M
- 5.3.9.1. Company overview
- 5.3.9.2. Financial performance
- 5.3.9.3. Product benchmarking
- 5.3.9.4. Strategic initiatives
- 5.3.10. Abbott
- 5.3.10.1. Company overview
- 5.3.10.2. Financial performance
- 5.3.10.3. Product benchmarking
- 5.3.10.4. Strategic initiatives
- 5.3.11. Baxter
- 5.3.11.1. Company overview
- 5.3.11.2. Financial performance
- 5.3.11.3. Product benchmarking
- 5.3.11.4. Strategic initiatives
- 5.3.12. B. Braun SE
- 5.3.12.1. Company overview
- 5.3.12.2. Financial performance
- 5.3.12.3. Product benchmarking
- 5.3.12.4. Strategic initiatives
- 5.3.13. GE HealthCare
- 5.3.13.1. Company overview
- 5.3.13.2. Financial performance
- 5.3.13.3. Product benchmarking
- 5.3.13.4. Strategic initiatives
- 5.3.14. Johnson & Johnson Services, Inc.
- 5.3.14.1. Company overview
- 5.3.14.2. Financial performance
- 5.3.14.3. Product benchmarking
- 5.3.14.4. Strategic initiatives
- 5.3.15. Medtronic
- 5.3.15.1. Company overview
- 5.3.15.2. Financial performance
- 5.3.15.3. Product benchmarking
- 5.3.15.4. Strategic initiatives
- 5.3.16. Boston Scientific Corporation
- 5.3.16.1. Company overview
- 5.3.16.2. Financial performance
- 5.3.16.3. Product benchmarking
- 5.3.16.4. Strategic initiatives
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviation
- Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
- Table 4 Key companies undergoing acquisitions/expansions
- Table 5 Key companies undergoing product launch/approval
- Table 6 Key companies undergoing partnership & collaboration
List of Figures
- Fig. 1 U.S. Medical Device Manufacturers market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Market formulation & validation
- Fig. 7 Market snapshot
- Fig. 8 Competitive landscape
- Fig. 9 Market Dynamics
- Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
- Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
- Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
- Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2023 & 2030
- Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
- Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
- Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
- Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
- Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
- Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
- Fig. 20 Others market, 2018 - 2030 (USD Billion)
- Fig. 21 Key company categorization
- Fig. 22 Heat map analysis
- Fig. 23 U.S orthopedic devices market share analysis, 2023
- Fig. 24 U.S cardiac care devices market share analysis, 2023
- Fig. 25 U.S drug delivery devices market share analysis, 2023
- Fig. 26 Strategic framework
